References
- CarruthersJDCarruthersJATreatment of glabellar frown lines with C. botulinum toxin exotoxinJ Dermatol Surg Oncol19921817211740562
- KimEJReeckJBMaasCSA validated scale for hyperkinetic facial linesArch Facial Plast Surg2004625325615262720
- AscherBZakineBKestemontPBaspeyrasMBougaraASantiniJA multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar linesJ Am Acad Dermatol20045122323315280841
- MonheitGCarruthersABrandtFRandRA randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal doseDermatol Surg200733S51S5917241415
- CarruthersJDCarruthersJACohenJDilution of botulinum toxin A for the treatment of glabellar rhytids: Does it matter?Dermatol Surg200733S97S10417241422
- HantashBMGladstoneHBA pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytidsDermatol Surg20073346146817430381
- WohlfarthKMüllerCSassinIComesGGrafeSNeurophysiological double-blind trial of a botulinum neurotoxin type A free of complexing proteinsClin Neuropharmacol200730869417414940
- KarsaiSAdrianRHammesSThimmJRaulinCA randomized, double-blind study of the effect of Botox and Dysport/Reloxin on forehead wrinkles and electromyographic actionArch Dermatol20071431447144918025375
- HeckmannMSchön-HupkaGQuantification of the efficacy of botulinum toxin type A by digital image analysisJ Am Acad Dermatol20014550851411568739
- CarruthersACarruthersJEyebrow height after botulinum toxin type A to the glabellaDermatol Surg200733S26S3117241411
- BeneckeRJostWHKnaovskyPRuzickaEComesGGrafeSA new botulinum toxin type A free of complexing proteins for treatment of focal dystoniaNeurology2005641949195115955951
- BlümelJFrevertJSchwaierAComparative antigenicity of three preparations of botulinum neurotoxin type A in the rabbitNeurotox Res20069 Abstract 238